Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.22 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 39.90.
Market Cap
8.22T
Revenue
4.52T
Profits
206.06B
PE Ratio
39.90
Profit Margin
4.56%
Dividend Yield
0.44%
1065 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 823.03B | 3.74% | 3,464,241 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 588.76B | 0.80% | 7,554,153 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 384.69B | 2.05% | 8,311,654 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 300.86B | 1.72% | 2,759,743 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 297.40B | 1.85% | 10,713,335 | 65.01B |
| 6 | NVS | Novartis AG | 287.51B | 1.59% | 2,003,399 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 245.61B | 3.36% | 9,170,779 | 447.57B |
| 8 | AMGN | Amgen Inc. | 189.67B | 0.82% | 3,747,125 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 182.60B | 2.39% | 2,272,063 | 44.56B |
| 10 | ABT | Abbott Laboratories | 178.82B | 0.78% | 12,442,102 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 172.99B | 2.22% | 7,878,992 | 29.44B |
| 12 | ISRG | Intuitive Surgical, Inc. | 163.73B | 1.81% | 1,960,307 | 10.06B |
| 13 | PFE | Pfizer Inc. | 159.73B | 1.12% | 44,841,499 | 62.58B |
| 14 | NVO | Novo Nordisk A/S | 158.15B | 4.14% | 18,979,197 | 48.59B |
| 15 | DHR | Danaher Corporation | 134.18B | 3.11% | 4,659,680 | 24.57B |
| 16 | SYK | Stryker Corporation | 125.75B | 1.04% | 2,391,445 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 123.83B | 1.54% | 12,797,241 | 48.19B |
| 18 | SNY | Sanofi | 115.17B | 3.13% | 3,219,124 | 54.85B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 113.44B | 0.76% | 1,624,941 | 12.00B |
| 20 | MDT | Medtronic plc | 111.25B | 1.06% | 7,342,182 | 35.48B |
| 21 | GSK | GSK plc | 108.95B | 1.77% | 5,532,363 | 43.97B |
| 22 | MCK | McKesson Corporation | 106.00B | 0.60% | 898,972 | 397.96B |
| 23 | HCA | HCA Healthcare, Inc. | 105.80B | 1.16% | 981,694 | 75.60B |
| 24 | BSX | Boston Scientific Corporation | 93.26B | -0.29% | 29,867,319 | 20.07B |
| 25 | CVS | CVS Health Corporation | 91.37B | 2.40% | 7,718,858 | 399.83B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 79.29B | 3.12% | 642,703 | 14.34B |
| 27 | CI | The Cigna Group | 70.33B | 3.36% | 1,509,517 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 64.31B | 2.80% | 2,455,579 | 199.13B |
| 29 | COR | Cencora, Inc. | 61.11B | 1.36% | 1,770,931 | 325.78B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 58.50B | 1.37% | 4,945,245 | 28.48B |
| 31 | MDLN | Medline Inc. | 58.46B | 4.41% | 12,160,560 | 28.43B |
| 32 | ZTS | Zoetis Inc. | 49.90B | 1.62% | 3,929,402 | 9.47B |
| 33 | CAH | Cardinal Health, Inc. | 49.72B | 2.42% | 1,587,255 | 244.67B |
| 34 | EW | Edwards Lifesciences Corporation | 46.17B | 0.73% | 4,426,339 | 6.07B |
| 35 | BDX | Becton, Dickinson and Company | 44.77B | 1.64% | 1,949,189 | 21.92B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.74B | 0.86% | 823,211 | 4.30B |
| 37 | ARGX | argenx SE | 44.42B | 3.68% | 370,176 | 4.24B |
| 38 | HLN | Haleon plc | 44.03B | 0.10% | 14,442,274 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.88B | 4.68% | 1,352,289 | 3.71B |
| 40 | ALC | Alcon Inc. | 36.01B | 2.28% | 1,594,429 | 10.40B |
| 41 | INSM | Insmed Incorporated | 35.25B | 6.65% | 3,673,904 | 606.42M |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 35.08B | 6.24% | 6,556,709 | 17.26B |
| 43 | ONC | BeOne Medicines AG | 32.93B | 4.54% | 233,046 | 5.34B |
| 44 | RMD | ResMed Inc. | 32.56B | 2.02% | 939,419 | 5.40B |
| 45 | GEHC | GE HealthCare Technologies Inc. | 32.48B | 3.50% | 3,496,608 | 20.63B |
| 46 | A | Agilent Technologies, Inc. | 32.21B | 1.99% | 2,469,448 | 7.07B |
| 47 | WAT | Waters Corporation | 29.21B | 1.51% | 1,270,150 | 3.17B |
| 48 | VEEV | Veeva Systems Inc. | 28.69B | -0.17% | 1,846,029 | 3.20B |
| 49 | IQV | IQVIA Holdings Inc. | 28.63B | 2.64% | 1,354,938 | 16.31B |
| 50 | NTRA | Natera, Inc. | 28.34B | 7.04% | 1,419,747 | 2.31B |
| 51 | RPRX | Royalty Pharma plc | 27.67B | 3.45% | 3,403,139 | 2.38B |
| 52 | BIIB | Biogen Inc. | 26.91B | -2.26% | 2,719,977 | 9.89B |
| 53 | UTHR | United Therapeutics Corporation | 25.99B | 0.79% | 1,461,355 | 3.18B |
| 54 | PHG | Koninklijke Philips N.V. | 25.60B | 3.28% | 1,158,403 | 20.94B |
| 55 | MTD | Mettler-Toledo International Inc. | 25.54B | 1.06% | 212,993 | 4.03B |
| 56 | DXCM | DexCom, Inc. | 24.17B | 1.45% | 3,977,820 | 4.66B |
| 57 | LH | Labcorp Holdings Inc. | 21.99B | 1.21% | 807,295 | 13.95B |
| 58 | STE | STERIS plc | 21.69B | 0.80% | 715,350 | 5.83B |
| 59 | DGX | Quest Diagnostics Incorporated | 21.53B | -0.60% | 1,268,736 | 11.04B |
| 60 | BNTX | BioNTech SE | 21.33B | 4.26% | 857,129 | 3.37B |
| 61 | HUM | Humana Inc. | 20.82B | 4.45% | 1,468,107 | 129.66B |
| 62 | MRNA | Moderna, Inc. | 20.15B | 5.33% | 8,182,670 | 1.94B |
| 63 | ROIV | Roivant Sciences Ltd. | 19.82B | 4.88% | 6,070,499 | 13.31M |
| 64 | RVMD | Revolution Medicines, Inc. | 19.27B | 4.90% | 3,247,538 | - |
| 65 | ILMN | Illumina, Inc. | 18.85B | 2.03% | 1,386,371 | 4.34B |
| 66 | INCY | Incyte Corporation | 18.73B | 4.20% | 1,826,385 | 5.14B |
| 67 | WST | West Pharmaceutical Services, Inc. | 18.05B | 2.24% | 797,792 | 3.07B |
| 68 | ZBH | Zimmer Biomet Holdings, Inc. | 17.69B | 2.31% | 1,903,893 | 8.23B |
| 69 | HOLX | Hologic, Inc. | 16.88B | 0.05% | 2,614,727 | 4.13B |
| 70 | THC | Tenet Healthcare Corporation | 16.41B | 0.38% | 1,493,427 | 21.31B |
| 71 | GMAB | Genmab A/S | 16.22B | 3.87% | 1,117,938 | 3.72B |
| 72 | CNC | Centene Corporation | 16.10B | 2.96% | 5,341,841 | 176.15B |
| 73 | VTRS | Viatris Inc. | 15.56B | 4.24% | 9,613,547 | 14.30B |
| 74 | PODD | Insulet Corporation | 14.77B | 0.88% | 751,658 | 2.71B |
| 75 | SMMT | Summit Therapeutics Inc. | 14.70B | 11.66% | 3,935,376 | - |
| 76 | BBIO | BridgeBio Pharma, Inc. | 14.40B | 7.06% | 2,336,819 | 502.08M |
| 77 | ASND | Ascendis Pharma A/S | 14.04B | 4.75% | 573,470 | 845.52M |
| 78 | COO | The Cooper Companies, Inc. | 13.95B | 3.16% | 1,858,875 | 4.15B |
| 79 | MEDP | Medpace Holdings, Inc. | 13.63B | 4.32% | 322,965 | 2.53B |
| 80 | SNN | Smith & Nephew plc | 13.30B | 0.60% | 519,388 | 6.16B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 13.22B | 2.35% | 1,339,187 | 2.86B |
| 82 | PEN | Penumbra, Inc. | 12.89B | 0.05% | 837,550 | 1.40B |
| 83 | RGC | Regencell Bioscience Holdings Limited | 12.57B | 9.00% | 102,338 | - |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 12.40B | 3.54% | 1,852,353 | 943.71M |
| 85 | ALGN | Align Technology, Inc. | 12.22B | 3.11% | 791,466 | 4.03B |
| 86 | GH | Guardant Health, Inc. | 12.12B | 7.16% | 3,001,226 | 982.02M |
| 87 | FMS | Fresenius Medical Care AG | 12.07B | 1.58% | 418,112 | 23.05B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.01B | 3.59% | 505,872 | 958.40M |
| 89 | ELAN | Elanco Animal Health Incorporated | 11.90B | 2.09% | 5,342,576 | 4.72B |
| 90 | GMED | Globus Medical, Inc. | 11.65B | 3.17% | 1,504,617 | 2.94B |
| 91 | JAZZ | Jazz Pharmaceuticals plc | 11.64B | 3.22% | 936,234 | 4.27B |
| 92 | ENSG | The Ensign Group, Inc. | 11.62B | 0.57% | 559,933 | 5.06B |
| 93 | SOLV | Solventum Corporation | 11.32B | 2.92% | 2,168,821 | 8.33B |
| 94 | EXEL | Exelixis, Inc. | 11.14B | 2.24% | 1,926,966 | 2.32B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 11.06B | 2.90% | 1,898,443 | 3.85B |
| 96 | UHS | Universal Health Services, Inc. | 10.93B | -1.72% | 698,189 | 17.36B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.86B | 3.10% | 2,526,788 | 3.22B |
| 98 | DVA | DaVita Inc. | 10.26B | 0.87% | 852,780 | 13.64B |
| 99 | RVTY | Revvity, Inc. | 9.80B | 3.34% | 1,255,992 | 2.86B |
| 100 | EHC | Encompass Health Corporation | 9.62B | -0.81% | 941,719 | 5.94B |
| 101 | MASI | Masimo Corporation | 9.29B | 0.31% | 1,328,223 | 1.53B |
| 102 | PRAX | Praxis Precision Medicines, Inc. | 8.97B | 16.55% | 640,271 | 7.46M |
| 103 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.78B | 8.76% | 2,060,356 | 1.09B |
| 104 | BTSG | BrightSpring Health Services, Inc. | 8.70B | 2.58% | 2,718,408 | 12.91B |
| 105 | BAX | Baxter International Inc. | 8.67B | 6.33% | 9,817,286 | 11.24B |
| 106 | AXSM | Axsome Therapeutics, Inc. | 8.65B | 5.31% | 677,101 | 638.50M |
| 107 | ABVX | ABIVAX Société Anonyme | 8.55B | 9.70% | 1,547,450 | 5.37M |
| 108 | CRL | Charles River Laboratories International, Inc. | 8.49B | 8.00% | 1,180,104 | 4.02B |
| 109 | HSIC | Henry Schein, Inc. | 8.45B | 1.38% | 1,033,428 | 13.18B |
| 110 | ICLR | ICON Public Limited Company | 8.45B | 5.29% | 1,190,155 | 8.10B |
| 111 | PCVX | Vaxcyte, Inc. | 8.36B | 5.73% | 1,876,393 | - |
| 112 | QGEN | Qiagen N.V. | 8.25B | 1.83% | 1,379,765 | 2.09B |
| 113 | TECH | Bio-Techne Corporation | 8.18B | 0.42% | 2,576,376 | 1.22B |
| 114 | CYTK | Cytokinetics, Incorporated | 8.12B | 4.67% | 1,731,643 | 88.04M |
| 115 | TEM | Tempus AI, Inc. | 8.08B | 6.73% | 4,251,832 | 1.27B |
| 116 | NUVL | Nuvalent, Inc. | 8.05B | 5.92% | 1,034,576 | - |
| 117 | ATR | AptarGroup, Inc. | 8.04B | 2.16% | 557,916 | 3.78B |
| 118 | IBRX | ImmunityBio, Inc. | 7.92B | 15.17% | 24,131,981 | 113.29M |
| 119 | HALO | Halozyme Therapeutics, Inc. | 7.66B | 4.02% | 1,818,214 | 1.40B |
| 120 | KRYS | Krystal Biotech, Inc. | 7.55B | 4.61% | 298,830 | 389.13M |
| 121 | BIO | Bio-Rad Laboratories, Inc. | 7.52B | 3.10% | 196,355 | 2.58B |
| 122 | HQY | HealthEquity, Inc. | 7.06B | 2.57% | 927,790 | 1.31B |
| 123 | MOH | Molina Healthcare, Inc. | 6.94B | 1.39% | 1,109,968 | 43.56B |
| 124 | KYMR | Kymera Therapeutics, Inc. | 6.80B | 4.79% | 1,313,873 | 39.21M |
| 125 | ACLX | Arcellx, Inc. | 6.74B | 0.04% | 1,072,494 | 22.29M |
| 126 | PTGX | Protagonist Therapeutics, Inc. | 6.73B | 5.54% | 944,904 | 46.02M |
| 127 | RGEN | Repligen Corporation | 6.64B | 5.68% | 1,285,842 | 738.26M |
| 128 | GRFS | Grifols, S.A. | 6.38B | 6.08% | 867,602 | 8.83B |
| 129 | BLTE | Belite Bio, Inc | 6.27B | 6.88% | 224,139 | - |
| 130 | GKOS | Glaukos Corporation | 6.25B | 2.52% | 627,562 | 507.44M |
| 131 | APGE | Apogee Therapeutics, Inc. | 6.22B | 6.92% | 1,423,791 | - |
| 132 | COGT | Cogent Biosciences, Inc. | 6.20B | 8.76% | 4,563,237 | - |
| 133 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | -0.30% | 12,806,199 | - |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.94B | 12.58% | 1,965,659 | 189.76M |
| 135 | ALKS | Alkermes plc | 5.88B | 17.28% | 12,031,520 | 1.48B |
| 136 | CNTA | Centessa Pharmaceuticals plc | 5.80B | 44.02% | 47,746,216 | 15.00M |
| 137 | CGON | CG Oncology, Inc. | 5.71B | 5.82% | 1,945,773 | 4.04M |
| 138 | SRRK | Scholar Rock Holding Corporation | 5.65B | 14.11% | 5,327,564 | - |
| 139 | PTCT | PTC Therapeutics, Inc. | 5.64B | 3.79% | 830,309 | 1.73B |
| 140 | BLCO | Bausch + Lomb Corporation | 5.63B | 4.19% | 772,270 | 5.10B |
| 141 | MIRM | Mirum Pharmaceuticals, Inc. | 5.57B | 5.10% | 1,769,284 | 521.31M |
| 142 | XENE | Xenon Pharmaceuticals Inc. | 5.55B | 4.68% | 1,554,886 | 7.50M |
| 143 | CELC | Celcuity Inc. | 5.52B | 5.42% | 521,467 | - |
| 144 | BRKR | Bruker Corporation | 5.50B | 5.28% | 1,988,956 | 3.44B |
| 145 | AVTR | Avantor, Inc. | 5.30B | 3.29% | 5,781,457 | 6.55B |
| 146 | TFX | Teleflex Incorporated | 5.29B | 4.07% | 692,532 | 1.99B |
| 147 | CHE | Chemed Corporation | 5.20B | 0.98% | 263,515 | 2.53B |
| 148 | APLS | Apellis Pharmaceuticals, Inc. | 5.14B | 135.40% | 90,709,595 | 1.00B |
| 149 | IMVT | Immunovant, Inc. | 5.06B | 5.48% | 1,819,451 | - |
| 150 | CAI | Caris Life Sciences, Inc. | 5.05B | 6.11% | 3,047,122 | 812.03M |
| 151 | PACS | PACS Group, Inc. | 5.05B | 5.73% | 821,671 | 5.29B |
| 152 | ERAS | Erasca, Inc. | 5.03B | 8.30% | 6,519,766 | - |
| 153 | LNTH | Lantheus Holdings, Inc. | 4.93B | 3.78% | 884,490 | 1.54B |
| 154 | TGTX | TG Therapeutics, Inc. | 4.91B | 5.43% | 3,232,168 | 616.29M |
| 155 | HIMS | Hims & Hers Health, Inc. | 4.73B | 10.54% | 34,530,514 | 2.35B |
| 156 | WAY | Waystar Holding Corp. | 4.62B | 2.77% | 3,568,940 | 1.10B |
| 157 | CRSP | CRISPR Therapeutics AG | 4.57B | 7.28% | 2,167,721 | 3.51M |
| 158 | FOLD | Amicus Therapeutics, Inc. | 4.54B | 0.21% | 2,620,030 | 634.21M |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 4.44B | 5.63% | 2,078,639 | 2.04M |
| 160 | RDNT | RadNet, Inc. | 4.34B | 0.27% | 858,464 | 2.04B |
| 161 | DOCS | Doximity, Inc. | 4.30B | -1.81% | 6,239,737 | 637.78M |
| 162 | CORT | Corcept Therapeutics Incorporated | 4.29B | 5.75% | 1,509,227 | 761.41M |
| 163 | OPCH | Option Care Health, Inc. | 4.21B | -0.30% | 2,326,777 | 5.65B |
| 164 | MMED | Minimed Group, Inc. | 4.19B | 3.97% | 1,550,104 | 2.89B |
| 165 | NVST | Envista Holdings Corporation | 4.16B | 4.58% | 3,864,461 | 2.72B |
| 166 | MMSI | Merit Medical Systems, Inc. | 4.10B | 0.42% | 648,857 | 1.52B |
| 167 | SHC | Sotera Health Company | 4.08B | 8.23% | 5,749,768 | 1.16B |
| 168 | LGND | Ligand Pharmaceuticals Incorporated | 3.98B | 3.64% | 196,174 | 268.09M |
| 169 | AMRX | Amneal Pharmaceuticals, Inc. | 3.97B | 4.02% | 1,783,357 | 3.02B |
| 170 | SYRE | Spyre Therapeutics, Inc. | 3.96B | 11.05% | 1,043,725 | - |
| 171 | IRTC | iRhythm Holdings, Inc. | 3.81B | 3.34% | 421,904 | 747.14M |
| 172 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.80B | 5.98% | 1,387,001 | 7.70M |
| 173 | ACAD | ACADIA Pharmaceuticals Inc. | 3.80B | 5.65% | 2,211,241 | 1.07B |
| 174 | VKTX | Viking Therapeutics, Inc. | 3.76B | 8.76% | 2,762,817 | - |
| 175 | STVN | Stevanato Group S.p.A. | 3.75B | 2.08% | 761,581 | 1.39B |
| 176 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.69B | 5.36% | 604,130 | 677.56M |
| 177 | NAMS | NewAmsterdam Pharma Company N.V. | 3.68B | 9.14% | 1,466,842 | 22.50M |
| 178 | BLLN | BillionToOne, Inc. | 3.63B | 12.59% | 300,634 | 305.11M |
| 179 | ALHC | Alignment Healthcare, Inc. | 3.60B | 4.57% | 4,066,045 | 3.95B |
| 180 | LIVN | LivaNova PLC | 3.48B | 3.74% | 1,133,854 | 1.39B |
| 181 | GPCR | Structure Therapeutics Inc. | 3.41B | 9.70% | 1,644,666 | - |
| 182 | OSCR | Oscar Health, Inc. | 3.41B | 5.71% | 6,838,496 | 11.70B |
| 183 | TMDX | TransMedics Group, Inc. | 3.41B | 5.41% | 971,578 | 605.49M |
| 184 | EWTX | Edgewise Therapeutics, Inc. | 3.38B | 4.03% | 1,122,826 | - |
| 185 | LEGN | Legend Biotech Corporation | 3.35B | 4.51% | 1,225,540 | 1.03B |
| 186 | LQDA | Liquidia Corporation | 3.33B | 7.28% | 1,597,804 | 158.32M |
| 187 | BKD | Brookdale Senior Living Inc. | 3.25B | 2.09% | 9,842,576 | 3.05B |
| 188 | ICUI | ICU Medical, Inc. | 3.23B | 3.01% | 226,728 | 2.23B |
| 189 | TLX | Telix Pharmaceuticals Limited | 3.07B | 6.81% | 242,868 | 803.79M |
| 190 | DNLI | Denali Therapeutics Inc. | 3.04B | 6.19% | 2,216,435 | - |
| 191 | HNGE | Hinge Health, Inc. | 3.04B | 4.87% | 1,248,225 | 587.86M |
| 192 | ITGR | Integer Holdings Corporation | 3.03B | 3.33% | 509,156 | 1.85B |
| 193 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.02B | 4.12% | 995,970 | 588.99M |
| 194 | DYN | Dyne Therapeutics, Inc. | 2.99B | 6.09% | 2,205,142 | - |
| 195 | TARS | Tarsus Pharmaceuticals, Inc. | 2.99B | 4.83% | 813,493 | 451.36M |
| 196 | TNGX | Tango Therapeutics, Inc. | 2.99B | 8.90% | 2,996,908 | 62.38M |
| 197 | SUPN | Supernus Pharmaceuticals, Inc. | 2.98B | 4.74% | 396,202 | 718.95M |
| 198 | IDYA | IDEAYA Biosciences, Inc. | 2.93B | 5.95% | 1,173,740 | 218.71M |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 2.92B | 10.45% | 2,062,646 | 376.07M |
| 200 | TWST | Twist Bioscience Corporation | 2.91B | 9.85% | 1,442,904 | 391.56M |
| 201 | VERA | Vera Therapeutics, Inc. | 2.87B | 5.59% | 1,849,509 | - |
| 202 | PBH | Prestige Consumer Healthcare Inc. | 2.80B | 1.30% | 434,091 | 1.10B |
| 203 | ALMS | Alumis Inc. | 2.80B | 9.01% | 2,772,095 | 24.05M |
| 204 | CON | Concentra Group Holdings Parent, Inc. | 2.76B | 1.90% | 906,981 | 2.16B |
| 205 | TVTX | Travere Therapeutics, Inc. | 2.74B | 7.41% | 1,848,494 | 490.73M |
| 206 | TXG | 10x Genomics, Inc. | 2.71B | 7.17% | 2,567,225 | 642.82M |
| 207 | RCUS | Arcus Biosciences, Inc. | 2.71B | 4.60% | 1,460,539 | 247.00M |
| 208 | HAE | Haemonetics Corporation | 2.62B | 2.60% | 536,628 | 1.32B |
| 209 | WRBY | Warby Parker Inc. | 2.58B | 3.59% | 2,088,794 | 871.91M |
| 210 | VCYT | Veracyte, Inc. | 2.56B | 5.81% | 1,082,292 | 517.15M |
| 211 | PRVA | Privia Health Group, Inc. | 2.54B | 2.75% | 824,395 | 2.12B |
| 212 | LMAT | LeMaitre Vascular, Inc. | 2.49B | 2.15% | 247,529 | 249.60M |
| 213 | LFST | LifeStance Health Group, Inc. | 2.48B | 2.08% | 1,892,974 | 1.42B |
| 214 | NHC | National HealthCare Corporation | 2.48B | -1.27% | 131,616 | 1.52B |
| 215 | IMNM | Immunome, Inc. | 2.47B | 13.32% | 4,211,422 | 6.94M |
| 216 | HCM | HUTCHMED (China) Limited | 2.45B | 4.62% | 28,847 | 548.51M |
| 217 | AAPG | Ascentage Pharma Group International | 2.44B | 3.11% | 2,249 | 82.08M |
| 218 | IRON | Disc Medicine, Inc. | 2.44B | 5.20% | 477,493 | - |
| 219 | ORKA | Oruka Therapeutics, Inc. | 2.43B | 7.75% | 1,028,189 | - |
| 220 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.39B | 0.74% | 5,655,327 | 874.84M |
| 221 | GRDN | Guardian Pharmacy Services, Inc. | 2.38B | 1.10% | 953,435 | 1.45B |
| 222 | BEAM | Beam Therapeutics Inc. | 2.37B | 8.81% | 2,393,463 | 139.74M |
| 223 | KOD | Kodiak Sciences Inc. | 2.36B | 13.25% | 2,557,289 | - |
| 224 | MANE | Veradermics, Incorporated | 2.36B | 3.78% | 818,693 | - |
| 225 | ELVN | Enliven Therapeutics, Inc. | 2.34B | 7.13% | 2,200,763 | - |
| 226 | XRAY | DENTSPLY SIRONA Inc. | 2.31B | 3.57% | 5,540,038 | 3.68B |
| 227 | SRPT | Sarepta Therapeutics, Inc. | 2.28B | 6.25% | 2,298,727 | 2.20B |
| 228 | PAHC | Phibro Animal Health Corporation | 2.24B | 3.67% | 322,447 | 1.46B |
| 229 | MLYS | Mineralys Therapeutics, Inc. | 2.23B | 15.23% | 2,509,170 | - |
| 230 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.09% | 964,978 | 158.18M |
| 231 | ACHC | Acadia Healthcare Company, Inc. | 2.15B | 2.45% | 1,853,289 | 3.31B |
| 232 | ADMA | ADMA Biologics, Inc. | 2.15B | -1.53% | 7,315,106 | 510.17M |
| 233 | ADPT | Adaptive Biotechnologies Corporation | 2.14B | 8.02% | 2,401,889 | 276.98M |
| 234 | GRAL | GRAIL, Inc. | 2.12B | 10.19% | 1,272,212 | 147.17M |
| 235 | ZLAB | Zai Lab Limited | 2.12B | 5.38% | 595,435 | 460.16M |
| 236 | CLDX | Celldex Therapeutics, Inc. | 2.11B | 7.60% | 1,369,565 | 1.55M |
| 237 | HTFL | HeartFlow, Inc. | 2.09B | 1.93% | 1,602,468 | 176.03M |
| 238 | NKTR | Nektar Therapeutics | 2.06B | 10.27% | 1,680,688 | 55.23M |
| 239 | TYRA | Tyra Biosciences, Inc. | 2.06B | 10.69% | 1,322,701 | - |
| 240 | SNDX | Syndax Pharmaceuticals, Inc. | 2.06B | 3.91% | 2,725,566 | 172.35M |
| 241 | RARE | Ultragenyx Pharmaceutical Inc. | 2.06B | 8.55% | 2,964,147 | 673.00M |
| 242 | NEOG | Neogen Corporation | 2.02B | 4.26% | 1,525,861 | 880.32M |
| 243 | SEM | Select Medical Holdings Corporation | 2.02B | - | 924,424 | 5.45B |
| 244 | MESO | Mesoblast Limited | 2.01B | 7.03% | 209,466 | 65.38M |
| 245 | BHC | Bausch Health Companies Inc. | 2.00B | 7.36% | 1,827,145 | 10.27B |
| 246 | VRDN | Viridian Therapeutics, Inc. | 2.00B | 5.56% | 4,476,969 | 70.85M |
| 247 | GLPG | Galapagos NV | 1.99B | 4.02% | 463,052 | 1.31B |
| 248 | AGIO | Agios Pharmaceuticals, Inc. | 1.98B | 14.25% | 3,606,789 | 54.03M |
| 249 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | 6.01% | 1,475,886 | 283.06M |
| 250 | AHG | Akso Health Group | 1.95B | -2.98% | 155,928 | 14.84M |
| 251 | STOK | Stoke Therapeutics, Inc. | 1.93B | 2.49% | 1,069,407 | 184.42M |
| 252 | DFTX | Definium Therapeutics, Inc. | 1.88B | 8.00% | 2,316,298 | - |
| 253 | WGS | GeneDx Holdings Corp. | 1.88B | 7.73% | 608,445 | 427.54M |
| 254 | ZYME | Zymeworks Inc. | 1.85B | 3.43% | 585,792 | 105.97M |
| 255 | OCUL | Ocular Therapeutix, Inc. | 1.84B | 14.46% | 5,429,790 | 51.95M |
| 256 | PHVS | Pharvaris N.V. | 1.84B | 3.52% | 563,734 | - |
| 257 | SION | Sionna Therapeutics, Inc. | 1.80B | 9.36% | 569,944 | - |
| 258 | PVLA | Palvella Therapeutics, Inc. | 1.78B | 12.64% | 556,318 | - |
| 259 | RLAY | Relay Therapeutics, Inc. | 1.78B | 6.42% | 2,178,688 | 15.36M |
| 260 | AORT | Artivion, Inc. | 1.75B | 3.42% | 447,389 | 441.33M |
| 261 | CAPR | Capricor Therapeutics, Inc. | 1.75B | 9.47% | 1,944,685 | 11.13M |
| 262 | MD | Pediatrix Medical Group, Inc. | 1.74B | 2.84% | 878,359 | 1.91B |
| 263 | SLNO | Soleno Therapeutics, Inc. | 1.73B | 9.99% | 3,056,912 | 190.41M |
| 264 | INVA | Innoviva, Inc. | 1.73B | 1.70% | 725,807 | 411.33M |
| 265 | AXGN | Axogen, Inc. | 1.72B | 5.78% | 1,135,684 | 225.21M |
| 266 | ADUS | Addus HomeCare Corporation | 1.70B | -0.77% | 226,760 | 1.42B |
| 267 | ESTA | Establishment Labs Holdings Inc. | 1.66B | 3.82% | 524,103 | 211.08M |
| 268 | ATEC | Alphatec Holdings, Inc. | 1.65B | -1.09% | 2,912,304 | 764.16M |
| 269 | VCEL | Vericel Corporation | 1.64B | 5.30% | 951,304 | 276.26M |
| 270 | RXRX | Recursion Pharmaceuticals, Inc. | 1.62B | 8.10% | 13,923,318 | 74.68M |
| 271 | HRMY | Harmony Biosciences Holdings, Inc. | 1.62B | 4.13% | 780,014 | 868.45M |
| 272 | AHCO | AdaptHealth Corp. | 1.62B | 5.40% | 2,191,079 | 3.24B |
| 273 | ANIP | ANI Pharmaceuticals, Inc. | 1.61B | 4.33% | 372,052 | 883.37M |
| 274 | NRIX | Nurix Therapeutics, Inc. | 1.60B | 5.66% | 1,669,362 | 83.98M |
| 275 | ANAB | AnaptysBio, Inc. | 1.59B | 0.13% | 810,614 | 234.60M |
| 276 | GENB | Generate Biomedicines, Inc. | 1.59B | 8.60% | 335,239 | 31.89M |
| 277 | OCS | Oculis Holding AG | 1.57B | 8.31% | 306,792 | 1.51M |
| 278 | DMRA | Damora Therapeutics, Inc. | 1.56B | 6.72% | 245,205 | - |
| 279 | OGN | Organon & Co. | 1.56B | 5.09% | 3,003,433 | 6.22B |
| 280 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.54B | 8.93% | 1,246,075 | -665.00K |
| 281 | TRVI | Trevi Therapeutics, Inc. | 1.53B | 6.61% | 1,030,743 | - |
| 282 | IMCR | Immunocore Holdings plc | 1.53B | 2.94% | 925,369 | 400.02M |
| 283 | SGRY | Surgery Partners, Inc. | 1.53B | 2.76% | 1,041,913 | 3.31B |
| 284 | OMCL | Omnicell, Inc. | 1.52B | 3.18% | 976,733 | 1.18B |
| 285 | NTLA | Intellia Therapeutics, Inc. | 1.51B | 10.04% | 4,201,751 | 67.67M |
| 286 | SNDA | Sonida Senior Living, Inc. | 1.51B | 3.20% | 689,917 | 336.39M |
| 287 | RAPP | Rapport Therapeutics, Inc. | 1.50B | 13.00% | 459,257 | - |
| 288 | UFPT | UFP Technologies, Inc. | 1.49B | 3.66% | 265,419 | 602.80M |
| 289 | INSP | Inspire Medical Systems, Inc. | 1.49B | 2.32% | 871,483 | 911.98M |
| 290 | MAZE | Maze Therapeutics, Inc. | 1.48B | 2.90% | 1,736,456 | 2.50M |
| 291 | PRGO | Perrigo Company plc | 1.48B | 10.49% | 5,033,100 | 4.25B |
| 292 | NUVB | Nuvation Bio Inc. | 1.47B | 5.93% | 4,234,468 | 62.90M |
| 293 | ARDX | Ardelyx, Inc. | 1.47B | 7.93% | 5,472,707 | 407.32M |
| 294 | PLSE | Pulse Biosciences, Inc. | 1.47B | 9.98% | 305,092 | 350.00K |
| 295 | IOVA | Iovance Biotherapeutics, Inc. | 1.45B | 5.72% | 10,974,150 | 263.50M |
| 296 | NBTX | Nanobiotix S.A. | 1.44B | 0.95% | 69,167 | 11.93M |
| 297 | VIR | Vir Biotechnology, Inc. | 1.43B | 5.91% | 1,995,340 | 68.56M |
| 298 | ATRC | AtriCure, Inc. | 1.42B | 0.96% | 470,273 | 534.53M |
| 299 | MBX | MBX Biosciences, Inc. | 1.42B | 10.88% | 522,692 | - |
| 300 | PRCT | PROCEPT BioRobotics Corporation | 1.41B | -2.11% | 1,191,100 | 308.05M |
| 301 | AVAH | Aveanna Healthcare Holdings Inc. | 1.40B | 0.94% | 1,782,818 | 2.43B |
| 302 | PGNY | Progyny, Inc. | 1.39B | 0.06% | 1,206,487 | 1.29B |
| 303 | SVRA | Savara Inc. | 1.38B | 8.12% | 1,870,212 | - |
| 304 | PGEN | Precigen, Inc. | 1.37B | 19.08% | 12,564,476 | 9.68M |
| 305 | WVE | Wave Life Sciences Ltd. | 1.36B | 9.52% | 12,407,968 | 42.73M |
| 306 | MLTX | MoonLake Immunotherapeutics | 1.34B | 10.10% | 3,015,209 | - |
| 307 | NVAX | Novavax, Inc. | 1.33B | 0.62% | 5,998,569 | 1.12B |
| 308 | IMTX | Immatics N.V. | 1.32B | 5.81% | 190,065 | 56.67M |
| 309 | GLUE | Monte Rosa Therapeutics, Inc. | 1.32B | 5.92% | 1,647,706 | 123.67M |
| 310 | HROW | Harrow, Inc. | 1.31B | 5.89% | 591,608 | 272.30M |
| 311 | TNDM | Tandem Diabetes Care, Inc. | 1.31B | -2.14% | 1,819,678 | 1.01B |
| 312 | HCSG | Healthcare Services Group, Inc. | 1.30B | -0.80% | 475,207 | 1.84B |
| 313 | ENOV | Enovis Corporation | 1.30B | 4.89% | 838,595 | 2.25B |
| 314 | BCAX | Bicara Therapeutics Inc. | 1.30B | 4.46% | 1,004,288 | - |
| 315 | OLMA | Olema Pharmaceuticals, Inc. | 1.30B | 11.10% | 1,345,352 | - |
| 316 | ATAI | AtaiBeckley Inc. | 1.29B | 4.12% | 3,022,203 | 4.09M |
| 317 | TSHA | Taysha Gene Therapies, Inc. | 1.28B | 9.83% | 3,617,702 | 9.77M |
| 318 | BHVN | Biohaven Ltd. | 1.27B | 4.57% | 5,721,269 | - |
| 319 | ORIC | ORIC Pharmaceuticals, Inc. | 1.27B | 3.94% | 1,848,707 | - |
| 320 | NVCR | NovoCure Limited | 1.24B | 5.21% | 1,217,443 | 655.35M |
| 321 | IRMD | IRADIMED CORPORATION | 1.23B | 1.38% | 114,182 | 83.81M |
| 322 | CRVS | Corvus Pharmaceuticals, Inc. | 1.23B | 9.18% | 1,282,269 | - |
| 323 | ARDT | Ardent Health, Inc. | 1.22B | 3.63% | 469,877 | 6.32B |
| 324 | ASTH | Astrana Health, Inc. | 1.21B | 0.74% | 402,916 | 3.18B |
| 325 | KMTS | Kestra Medical Technologies, Ltd. | 1.16B | 8.73% | 695,159 | 83.72M |
| 326 | ZBIO | Zenas BioPharma, Inc. | 1.16B | 7.24% | 2,564,856 | 10.00M |
| 327 | DBVT | DBV Technologies S.A. | 1.16B | 6.80% | 395,228 | 5.64M |
| 328 | USPH | U.S. Physical Therapy, Inc. | 1.13B | 0.23% | 137,518 | 773.34M |
| 329 | PHAR | Pharming Group N.V. | 1.13B | 3.94% | 18,079 | 376.13M |
| 330 | NNNN | Anbio Biotechnology | 1.13B | 4.39% | 21,247 | 6.92M |
| 331 | QDEL | QuidelOrtho Corporation | 1.12B | 7.67% | 2,100,956 | 2.73B |
| 332 | CNMD | CONMED Corporation | 1.09B | 5.58% | 499,356 | 1.37B |
| 333 | INNV | InnovAge Holding Corp. | 1.09B | 1.91% | 266,766 | 915.37M |
| 334 | SEPN | Septerna, Inc. | 1.08B | 3.13% | 257,857 | 45.95M |
| 335 | EYPT | EyePoint, Inc. | 1.08B | 8.78% | 1,844,118 | 31.37M |
| 336 | ALVO | Alvotech | 1.07B | 4.26% | 602,869 | 588.90M |
| 337 | ABCL | AbCellera Biologics Inc. | 1.06B | 6.40% | 2,989,163 | 75.13M |
| 338 | PNTG | The Pennant Group, Inc. | 1.06B | 1.13% | 189,527 | 947.71M |
| 339 | COLL | Collegium Pharmaceutical, Inc. | 1.05B | 3.38% | 782,443 | 780.57M |
| 340 | IVA | Inventiva S.A. | 1.05B | 1.28% | 954,177 | 9.31M |
| 341 | KALV | KalVista Pharmaceuticals, Inc. | 1.03B | 9.64% | 1,959,784 | 73.62M |
| 342 | BFLY | Butterfly Network, Inc. | 1.03B | 5.48% | 4,306,117 | 97.61M |
| 343 | QURE | uniQure N.V. | 1.02B | 11.00% | 1,716,937 | 16.10M |
| 344 | AVBP | ArriVent BioPharma, Inc. | 1.02B | 9.80% | 505,974 | - |
| 345 | CTMX | CytomX Therapeutics, Inc. | 1.02B | 6.58% | 3,813,681 | 76.20M |
| 346 | XERS | Xeris Biopharma Holdings, Inc. | 1.00B | 3.57% | 2,017,480 | 291.85M |
| 347 | SSII | SS Innovations International, Inc. | 999.70M | 1.63% | 82,232 | 42.48M |
| 348 | INBX | Inhibrx Biosciences, Inc. | 982.03M | 12.27% | 256,708 | 1.30M |
| 349 | AZTA | Azenta, Inc. | 973.28M | 4.35% | 982,932 | 595.03M |
| 350 | TDOC | Teladoc Health, Inc. | 972.26M | 6.03% | 7,723,218 | 2.53B |
| 351 | NEO | NeoGenomics, Inc. | 963.21M | 3.06% | 1,261,247 | 727.33M |
| 352 | CRON | Cronos Group Inc. | 955.87M | 2.87% | 656,881 | 146.59M |
| 353 | GERN | Geron Corporation | 954.41M | 5.67% | 14,404,602 | 183.88M |
| 354 | CMPX | Compass Therapeutics, Inc. | 952.67M | 3.73% | 4,366,987 | 850.00K |
| 355 | AKTS | Aktis Oncology, Inc. | 939.62M | 8.16% | 1,184,228 | 6.50M |
| 356 | STAA | STAAR Surgical Company | 925.89M | 1.96% | 723,982 | 239.44M |
| 357 | CLOV | Clover Health Investments, Corp. | 923.41M | 2.33% | 6,837,264 | 1.92B |
| 358 | BLFS | BioLife Solutions, Inc. | 921.56M | 1.60% | 289,886 | 96.21M |
| 359 | PCRX | Pacira BioSciences, Inc. | 915.07M | -2.88% | 657,773 | 726.41M |
| 360 | CERT | Certara, Inc. | 907.10M | 0.35% | 9,997,985 | 418.84M |
| 361 | MPLT | MapLight Therapeutics, Inc. | 895.01M | 8.66% | 245,848 | - |
| 362 | CDNA | CareDx, Inc. | 889.12M | 5.66% | 863,011 | 379.81M |
| 363 | ANNX | Annexon, Inc. | 889.03M | 11.69% | 4,932,584 | - |
| 364 | AMPH | Amphastar Pharmaceuticals, Inc. | 888.80M | 1.93% | 534,427 | 719.89M |
| 365 | XNCR | Xencor, Inc. | 884.46M | 6.26% | 1,090,536 | 125.58M |
| 366 | FTRE | Fortrea Holdings Inc. | 880.77M | 6.20% | 1,315,084 | 2.72B |
| 367 | ABUS | Arbutus Biopharma Corporation | 879.65M | 4.65% | 2,063,277 | 14.08M |
| 368 | EVO | Evotec SE | 877.11M | 5.93% | 67,913 | 887.40M |
| 369 | PHAT | Phathom Pharmaceuticals, Inc. | 875.45M | 5.51% | 1,212,678 | 175.11M |
| 370 | URGN | UroGen Pharma Ltd. | 875.31M | 5.76% | 691,640 | 109.79M |
| 371 | GHRS | GH Research PLC | 872.13M | 7.90% | 171,764 | - |
| 372 | INMD | InMode Ltd. | 866.75M | 2.01% | 1,088,449 | 370.50M |
| 373 | OPK | OPKO Health, Inc. | 865.34M | 3.64% | 2,573,533 | 606.88M |
| 374 | TALK | Talkspace, Inc. | 864.62M | -0.10% | 1,368,503 | 228.87M |
| 375 | SGP | SpyGlass Pharma, Inc. | 863.25M | 10.87% | 91,155 | - |
| 376 | CGEM | Cullinan Therapeutics, Inc. | 860.08M | 5.89% | 1,074,931 | - |
| 377 | JANX | Janux Therapeutics, Inc. | 845.56M | 6.68% | 1,132,954 | 10.00M |
| 378 | SDGR | Schrödinger, Inc. | 838.65M | 2.62% | 753,193 | 255.87M |
| 379 | TBPH | Theravance Biopharma, Inc. | 835.73M | 6.36% | 816,200 | 107.46M |
| 380 | EVMN | Evommune, Inc. | 828.06M | 4.50% | 362,884 | 13.00M |
| 381 | LMRI | Lumexa Imaging Holdings, Inc. | 826.55M | 7.90% | 1,191,176 | 1.02B |
| 382 | TENX | Tenax Therapeutics, Inc. | 804.30M | 14.13% | 610,394 | - |
| 383 | SPRY | ARS Pharmaceuticals, Inc. | 797.36M | 2.69% | 1,850,435 | 84.28M |
| 384 | BIOA | BioAge Labs, Inc. | 776.20M | 10.49% | 885,951 | 9.00M |
| 385 | SANA | Sana Biotechnology, Inc. | 768.58M | 7.46% | 3,473,212 | - |
| 386 | SLS | SELLAS Life Sciences Group, Inc. | 759.63M | 5.62% | 8,314,097 | - |
| 387 | BVS | Bioventus Inc. | 759.20M | 1.90% | 582,045 | 568.09M |
| 388 | MNKD | MannKind Corporation | 754.85M | 3.38% | 4,843,967 | 348.97M |
| 389 | TLRY | Tilray Brands, Inc. | 753.80M | 8.01% | 3,795,438 | 837.32M |
| 390 | OMER | Omeros Corporation | 748.71M | 7.65% | 1,793,020 | - |
| 391 | VOR | Vor Biopharma Inc. | 740.71M | 21.36% | 2,462,215 | - |
| 392 | OMDA | Omada Health, Inc. | 740.69M | 4.32% | 1,273,055 | 260.21M |
| 393 | IART | Integra LifeSciences Holdings Corporation | 734.17M | 3.29% | 795,401 | 1.64B |
| 394 | RLMD | Relmada Therapeutics, Inc. | 730.04M | 9.09% | 2,187,173 | - |
| 395 | CSTL | Castle Biosciences, Inc. | 729.90M | 4.25% | 431,483 | 344.23M |
| 396 | MRVI | Maravai LifeSciences Holdings, Inc. | 727.50M | -1.74% | 2,123,807 | 185.74M |
| 397 | ANRO | Alto Neuroscience, Inc. | 718.14M | 12.51% | 744,204 | - |
| 398 | KURA | Kura Oncology, Inc. | 718.12M | 5.17% | 1,392,729 | 67.48M |
| 399 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 716.29M | 3.11% | 196,091 | - |
| 400 | EHAB | Enhabit, Inc. | 714.69M | 0.28% | 1,317,080 | 1.06B |
| 401 | CMPS | COMPASS Pathways plc | 712.95M | 5.53% | 1,988,982 | - |
| 402 | DRUG | Bright Minds Biosciences Inc. | 710.76M | 6.60% | 206,319 | - |
| 403 | AMN | AMN Healthcare Services, Inc. | 708.96M | -2.08% | 669,159 | 2.73B |
| 404 | SLDB | Solid Biosciences Inc. | 708.42M | 10.94% | 2,022,890 | - |
| 405 | MGTX | MeiraGTx Holdings plc | 705.32M | 7.05% | 1,528,246 | 81.39M |
| 406 | ESPR | Esperion Therapeutics, Inc. | 703.66M | 4.18% | 7,314,491 | 403.14M |
| 407 | JBIO | Jade Biosciences, Inc. | 692.89M | 5.96% | 724,871 | - |
| 408 | CBLL | CeriBell, Inc. | 689.96M | 3.21% | 438,545 | 89.06M |
| 409 | ARVN | Arvinas, Inc. | 677.99M | 4.13% | 1,144,626 | 262.60M |
| 410 | ETON | Eton Pharmaceuticals, Inc. | 673.38M | 9.30% | 717,564 | 79.95M |
| 411 | GDRX | GoodRx Holdings, Inc. | 671.45M | 2.62% | 1,279,469 | 796.85M |
| 412 | PSNL | Personalis, Inc. | 666.50M | 2.08% | 2,180,017 | 69.65M |
| 413 | NUTX | Nutex Health Inc. | 662.27M | 4.55% | 115,633 | 875.26M |
| 414 | LXRX | Lexicon Pharmaceuticals, Inc. | 660.94M | 3.31% | 1,754,934 | 49.80M |
| 415 | DSGN | Design Therapeutics, Inc. | 656.19M | 2.60% | 267,928 | - |
| 416 | AVNS | Avanos Medical, Inc. | 651.57M | 2.04% | 368,362 | 701.20M |
| 417 | GYRE | Gyre Therapeutics, Inc. | 636.46M | 1.90% | 97,641 | 116.59M |
| 418 | REPL | Replimune Group, Inc. | 631.68M | 6.25% | 2,130,427 | - |
| 419 | LBRX | LB Pharmaceuticals Inc | 623.88M | 6.06% | 312,961 | - |
| 420 | DRTS | Alpha Tau Medical Ltd. | 622.23M | 7.94% | 210,813 | - |
| 421 | PRME | Prime Medicine, Inc. | 616.24M | 10.48% | 2,034,738 | 4.63M |
| 422 | OCGN | Ocugen, Inc. | 611.59M | 3.43% | 7,515,962 | 4.41M |
| 423 | CBIO | Crescent Biopharma, Inc. | 610.14M | 10.53% | 199,574 | 10.84M |
| 424 | HSTM | HealthStream, Inc. | 607.97M | -1.80% | 287,576 | 304.06M |
| 425 | ALLO | Allogene Therapeutics, Inc. | 594.82M | 9.91% | 3,682,842 | 22.00K |
| 426 | TCMD | Tactile Systems Technology, Inc. | 594.47M | 0.97% | 342,659 | 329.52M |
| 427 | MDXG | MiMedx Group, Inc. | 586.84M | 2.33% | 1,575,247 | 418.63M |
| 428 | TECX | Tectonic Therapeutic, Inc. | 580.39M | 7.07% | 152,780 | - |
| 429 | IRWD | Ironwood Pharmaceuticals, Inc. | 572.33M | 8.67% | 3,159,600 | 296.15M |
| 430 | EIKN | Eikon Therapeutics, Inc. | 571.15M | 9.30% | 474,349 | - |
| 431 | VALN | Valneva SE | 564.95M | 0.97% | 368,103 | 205.07M |
| 432 | ZURA | Zura Bio Limited | 564.54M | 4.75% | 637,952 | - |
| 433 | CTKB | Cytek Biosciences, Inc. | 561.76M | 1.63% | 584,151 | 201.49M |
| 434 | SIBN | SI-BONE, Inc. | 557.81M | 2.85% | 599,430 | 200.93M |
| 435 | ZVRA | Zevra Therapeutics, Inc. | 547.19M | 6.15% | 931,212 | 106.47M |
| 436 | BWAY | BrainsWay Ltd. | 543.19M | 4.15% | 151,950 | 52.23M |
| 437 | YDES | YD Bio Limited | 541.46M | -4.94% | 14,451 | 510.36K |
| 438 | PROK | ProKidney Corp. | 540.43M | 10.49% | 1,352,114 | 893.00K |
| 439 | CRMD | CorMedix Inc. | 536.75M | 3.35% | 1,237,302 | 311.71M |
| 440 | AVR | Anteris Technologies Global Corp. | 525.84M | 8.61% | 1,515,638 | 1.91M |
| 441 | EMBC | Embecta Corp. | 523.50M | - | 1,044,213 | 1.08B |
| 442 | PRTA | Prothena Corporation plc | 523.26M | 5.08% | 671,533 | 9.68M |
| 443 | KYTX | Kyverna Therapeutics, Inc. | 521.73M | 13.85% | 909,287 | - |
| 444 | ACRS | Aclaris Therapeutics, Inc. | 521.23M | 7.45% | 2,115,560 | 7.83M |
| 445 | AGMB | AgomAb Therapeutics NV | 511.25M | 6.39% | 495,001 | - |
| 446 | FULC | Fulcrum Therapeutics, Inc. | 510.82M | 16.57% | 4,644,564 | 80.00M |
| 447 | PHR | Phreesia, Inc. | 508.37M | -26.56% | 16,319,072 | 480.59M |
| 448 | AQST | Aquestive Therapeutics, Inc. | 506.49M | 2.72% | 1,238,065 | 44.55M |
| 449 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 6.22M |
| 450 | RIGL | Rigel Pharmaceuticals, Inc. | 499.51M | 5.13% | 208,948 | 294.28M |
| 451 | FLGT | Fulgent Genetics, Inc. | 496.57M | 1.73% | 499,647 | 322.67M |
| 452 | VTVT | vTv Therapeutics Inc. | 492.16M | 8.07% | 54,559 | 17.00K |
| 453 | NAUT | Nautilus Biotechnology, Inc. | 491.07M | 13.12% | 387,874 | - |
| 454 | UPB | Upstream Bio, Inc. | 489.78M | 2.51% | 1,034,695 | 2.85M |
| 455 | CTNM | Contineum Therapeutics, Inc. | 487.61M | 4.82% | 430,095 | - |
| 456 | IMMX | Immix Biopharma, Inc. | 482.51M | 6.18% | 1,221,830 | - |
| 457 | ADCT | ADC Therapeutics SA | 476.42M | 3.02% | 919,139 | 81.36M |
| 458 | FDMT | 4D Molecular Therapeutics, Inc. | 475.29M | 8.63% | 705,119 | 85.21M |
| 459 | KMDA | Kamada Ltd. | 475.22M | 3.35% | 51,819 | 180.46M |
| 460 | CATX | Perspective Therapeutics, Inc. | 475.10M | 8.88% | 1,549,891 | 884.00K |
| 461 | ANGO | AngioDynamics, Inc. | 468.64M | 4.60% | 488,639 | 307.31M |
| 462 | LYEL | Lyell Immunopharma, Inc. | 467.54M | 3.99% | 112,467 | 36.00K |
| 463 | LRMR | Larimar Therapeutics, Inc. | 467.47M | 4.41% | 1,750,909 | - |
| 464 | VSTM | Verastem, Inc. | 465.53M | 9.28% | 3,579,780 | 30.91M |
| 465 | FBRX | Forte Biosciences, Inc. | 461.83M | -1.60% | 267,593 | - |
| 466 | OFIX | Orthofix Medical Inc. | 460.46M | 1.33% | 258,210 | 822.31M |
| 467 | STTK | Shattuck Labs, Inc. | 460.16M | 7.89% | 513,270 | 1.00M |
| 468 | ABSI | Absci Corporation | 459.06M | 8.70% | 3,798,684 | 2.80M |
| 469 | ENGN | enGene Holdings Inc. | 456.20M | 10.19% | 244,164 | - |
| 470 | TRDA | Entrada Therapeutics, Inc. | 454.32M | 7.22% | 266,030 | 25.42M |
| 471 | VREX | Varex Imaging Corporation | 444.77M | 2.61% | 258,360 | 854.40M |
| 472 | BBNX | Beta Bionics, Inc. | 444.71M | 1.62% | 2,038,992 | 100.25M |
| 473 | NPCE | NeuroPace, Inc. | 442.72M | 2.41% | 297,417 | 99.99M |
| 474 | EPRX | Eupraxia Pharmaceuticals Inc. | 442.37M | 9.53% | 141,072 | - |
| 475 | ASMB | Assembly Biosciences, Inc. | 440.19M | 4.17% | 97,647 | 72.30M |
| 476 | RGNX | REGENXBIO Inc. | 432.52M | 7.85% | 566,686 | 170.44M |
| 477 | AURA | Aura Biosciences, Inc. | 429.17M | 7.90% | 340,169 | - |
| 478 | EBS | Emergent BioSolutions Inc. | 428.65M | 3.11% | 760,324 | 742.90M |
| 479 | AVIR | Atea Pharmaceuticals, Inc. | 428.64M | 5.91% | 325,173 | - |
| 480 | LXEO | Lexeo Therapeutics, Inc. | 425.26M | 8.92% | 1,390,545 | - |
| 481 | MYGN | Myriad Genetics, Inc. | 420.79M | 3.21% | 1,226,014 | 824.50M |
| 482 | STRO | Sutro Biopharma, Inc. | 412.69M | 3.36% | 105,650 | 102.48M |
| 483 | VNDA | Vanda Pharmaceuticals Inc. | 408.44M | 3.91% | 1,463,016 | 216.11M |
| 484 | AUNA | Auna S.A. | 407.81M | 4.36% | 184,270 | 1.30B |
| 485 | IPSC | Century Therapeutics, Inc. | 406.17M | 11.33% | 924,827 | 109.16M |
| 486 | KIDS | OrthoPediatrics Corp. | 401.17M | 4.41% | 255,470 | 236.35M |
| 487 | ALT | Altimmune, Inc. | 400.72M | 6.94% | 3,290,533 | 41.00K |
| 488 | PACB | Pacific Biosciences of California, Inc. | 398.64M | 4.76% | 9,644,221 | 160.01M |
| 489 | CYH | Community Health Systems, Inc. | 393.56M | 2.44% | 1,482,616 | 12.49B |
| 490 | LCTX | Lineage Cell Therapeutics, Inc. | 393.56M | 7.48% | 1,022,329 | 14.56M |
| 491 | RCKT | Rocket Pharmaceuticals, Inc. | 388.68M | 3.92% | 4,467,222 | - |
| 492 | NRC | National Research Corporation | 386.23M | -0.93% | 66,248 | 137.39M |
| 493 | SIGA | SIGA Technologies, Inc. | 383.30M | 1.71% | 986,350 | 94.57M |
| 494 | XFOR | X4 Pharmaceuticals, Inc. | 375.50M | 3.51% | 375,778 | 35.11M |
| 495 | ARMP | Armata Pharmaceuticals, Inc. | 375.12M | 19.21% | 21,227 | 4.90M |
| 496 | XOMA | XOMA Royalty Corporation | 373.80M | 3.70% | 123,624 | 52.15M |
| 497 | AKBA | Akebia Therapeutics, Inc. | 372.35M | 5.30% | 1,898,056 | 236.20M |
| 498 | IVVD | Invivyd, Inc. | 367.37M | 9.24% | 4,064,548 | 53.43M |
| 499 | AUTL | Autolus Therapeutics plc | 367.28M | 8.66% | 3,451,436 | 75.39M |
| 500 | ENTA | Enanta Pharmaceuticals, Inc. | 366.51M | 3.69% | 107,549 | 66.98M |